Peter von Dadelszen1, Diane Sawchuck, Romy McMaster, M Joanne Douglas, Shoo K Lee, Sarah Saunders, Robert M Liston, Laura A Magee. 1. Departments of Obstetrics and Gynaecology, Anesthesiology, Pharmacology and Therapeutics, and Medicine, School of Public and Population Health, Child and Family Research Institute, and Faculty of Medicine, University of British Columbia, and the BC Perinatal Health Program, Vancouver, British Columbia, Canada. pvd@cw.bc.ca
Abstract
OBJECTIVE: To reduce maternal and perinatal morbidity and mortality associated with the hypertensive disorders of pregnancy by using an active model of guideline implementation. METHODS: This study used a preintervention and postintervention cohort comparison design. We interrogated the British Columbia Perinatal Database Registry for 6 years of existing prospectively gathered data (fiscal years 2000-2001 to 2005-2006), introduced the hypertensive disorders of pregnancy guidelines, and assessed the incidence of the combined adverse maternal and perinatal outcomes for the next 2 years (fiscal years 2006-2007 and 2007-2008). The combined adverse maternal outcome was maternal death, life-threatening, or life-altering complications. The combined perinatal outcome included the severe complications of prematurity and hypoxic-ischemic encephalopathy. RESULTS: Eighteen thousand seventy-six women were diagnosed with hypertensive disorder of pregnancy in British Columbia from 2000-2001 to 2007-2008. Outcomes were compared preguideline (n=13,150 deliveries) and postguideline (n=4,926 deliveries) implementation. The incidence of the combined adverse maternal outcome decreased from 3.1% to 1.9% (relative risk 0.60, 95% confidence interval 0.48-0.75). There was a concomitant fall in the incidence of the combined adverse perinatal outcome. CONCLUSION: The active introduction of standardized management of women with a hypertensive disorder of pregnancy is associated with reduced maternal and perinatal risk. LEVEL OF EVIDENCE: II.
OBJECTIVE: To reduce maternal and perinatal morbidity and mortality associated with the hypertensive disorders of pregnancy by using an active model of guideline implementation. METHODS: This study used a preintervention and postintervention cohort comparison design. We interrogated the British Columbia Perinatal Database Registry for 6 years of existing prospectively gathered data (fiscal years 2000-2001 to 2005-2006), introduced the hypertensive disorders of pregnancy guidelines, and assessed the incidence of the combined adverse maternal and perinatal outcomes for the next 2 years (fiscal years 2006-2007 and 2007-2008). The combined adverse maternal outcome was maternal death, life-threatening, or life-altering complications. The combined perinatal outcome included the severe complications of prematurity and hypoxic-ischemicencephalopathy. RESULTS: Eighteen thousand seventy-six women were diagnosed with hypertensive disorder of pregnancy in British Columbia from 2000-2001 to 2007-2008. Outcomes were compared preguideline (n=13,150 deliveries) and postguideline (n=4,926 deliveries) implementation. The incidence of the combined adverse maternal outcome decreased from 3.1% to 1.9% (relative risk 0.60, 95% confidence interval 0.48-0.75). There was a concomitant fall in the incidence of the combined adverse perinatal outcome. CONCLUSION: The active introduction of standardized management of women with a hypertensive disorder of pregnancy is associated with reduced maternal and perinatal risk. LEVEL OF EVIDENCE: II.
Authors: Katherine C Teela; Dane A De Silva; Katie Chapman; Anne R Synnes; Diane Sawchuck; Melanie Basso; Robert M Liston; Peter von Dadelszen; Laura A Magee Journal: BMC Pregnancy Childbirth Date: 2015-12-22 Impact factor: 3.007
Authors: A E Seijmonsbergen-Schermers; D C Zondag; M Nieuwenhuijze; T Van den Akker; C J Verhoeven; C Geerts; F Schellevis; A De Jonge Journal: BMC Pregnancy Childbirth Date: 2018-06-01 Impact factor: 3.007
Authors: Wallace Andrino da Silva; Carlo Victor A Varela; Aline Macedo Pinheiro; Paula Castro Scherer; Rossana P V Francisco; Marcelo Luis Abramides Torres; Maria José C Carmona; Fernando Bliacheriene; Lúcia C Andrade; Paolo Pelosi; Luiz Marcelo S Malbouisson Journal: Clinics (Sao Paulo) Date: 2020-07-22 Impact factor: 2.365
Authors: Mrutunjaya B Bellad; Shivaprasad S Goudar; Ashalata A Mallapur; Sumedha Sharma; Jeffrey Bone; Umesh S Charantimath; Geetanjali M Katageri; Umesh Y Ramadurg; J Mark Ansermino; Richard J Derman; Dustin T Dunsmuir; Narayan V Honnungar; Chandrashekhar Karadiguddi; Avinash J Kavi; Bhalachandra S Kodkany; Tang Lee; Jing Li; Hannah L Nathan; Beth A Payne; Amit P Revankar; Andrew H Shennan; Joel Singer; Domena K Tu; Marianne Vidler; Hubert Wong; Zulfiqar A Bhutta; Laura A Magee; Peter von Dadelszen Journal: Pregnancy Hypertens Date: 2020-05-19 Impact factor: 2.899
Authors: Marcos Augusto Bastos Dias; Leandro De Oliveira; Arundhanthi Jeyabalan; Beth Payne; Christopher W Redman; Laura Magee; Lucilla Poston; Lucy Chappell; Paul Seed; Peter von Dadelszen; James Michael Roberts Journal: BMC Pregnancy Childbirth Date: 2019-10-07 Impact factor: 3.007
Authors: Azar Mehrabadi; Shiliang Liu; Sharon Bartholomew; Jennifer A Hutcheon; Laura A Magee; Michael S Kramer; Robert M Liston; K S Joseph Journal: BMJ Date: 2014-07-30
Authors: Lisiane Freitas Leal; Sonia Marzia Grandi; Vanessa Iribarrem Avena Miranda; Tatiane da Silva Dal Pizzol; Robert William Platt; Mariângela Freitas da Silveira; Andréa Dâmaso Bertoldi Journal: Int J Environ Res Public Health Date: 2020-11-18 Impact factor: 3.390